Results
Revise Search
-
Filters:
- All Records
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- 2001
- 1985
- 2006
Recommendations pertaining to children's mental health
https://policybase.cma.ca/en/permalink/policy8507
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Health systems, system funding and performance
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC06-15
- The Canadian Medical Association endorses all of the recommendations pertaining to children's mental health in the Senate report, Out of the Shadows at Last - Transforming Mental Health, Mental Illness and Addiction Services in Canada.
- Policy Type
- Policy resolution
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Health systems, system funding and performance
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC06-15
- The Canadian Medical Association endorses all of the recommendations pertaining to children's mental health in the Senate report, Out of the Shadows at Last - Transforming Mental Health, Mental Illness and Addiction Services in Canada.
Insurance fund of last resort
https://policybase.cma.ca/en/permalink/policy8520
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Population health/ health equity/ public health
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC06-16
- The Canadian Medical Association urges governments to create an insurance fund of last resort to provide financial relief to parents for the catastrophic cost of drugs and other health care services provided to children as part of an accepted treatment protocol for childhood illnesses and disorders when not covered by public insurance.
- Policy Type
- Policy resolution
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Population health/ health equity/ public health
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC06-16
- The Canadian Medical Association urges governments to create an insurance fund of last resort to provide financial relief to parents for the catastrophic cost of drugs and other health care services provided to children as part of an accepted treatment protocol for childhood illnesses and disorders when not covered by public insurance.
Sale of clove, herbal and vitamin cigarettes
https://policybase.cma.ca/en/permalink/policy8547
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC06-77
- The Canadian Medical Association will work with the federal government to study the possibility of national legislation governing the promotion and sale of clove, herbal and vitamin cigarettes.
- Policy Type
- Policy resolution
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Population health/ health equity/ public health
- Resolution
- GC06-77
- The Canadian Medical Association will work with the federal government to study the possibility of national legislation governing the promotion and sale of clove, herbal and vitamin cigarettes.
Pharmacists who are given independent prescribing authority
https://policybase.cma.ca/en/permalink/policy8557
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Population health/ health equity/ public health
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Health care and patient safety
- Resolution
- GC06-67
- The Canadian Medical Association, in conjunction with its divisions and affiliates, without endorsing pharmacist independent prescribing strongly urges the Government of Alberta to require pharmacists who are given independent prescribing authority to: a) require explicit, informed consent from a patient; b) maintain a patient's record; c) provide 24-hour availability to the patient; d) carry appropriate coverage for legal liability; e) disclose any potential conflict of interest as both a prescriber and dispenser of medication; and, f) if the pharmacist changes a physician's prescription, advise the physician of the change(s).
- Policy Type
- Policy resolution
- Last Reviewed
- 2020-02-29
- Date
- 2006-08-23
- Topics
- Population health/ health equity/ public health
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Health care and patient safety
- Resolution
- GC06-67
- The Canadian Medical Association, in conjunction with its divisions and affiliates, without endorsing pharmacist independent prescribing strongly urges the Government of Alberta to require pharmacists who are given independent prescribing authority to: a) require explicit, informed consent from a patient; b) maintain a patient's record; c) provide 24-hour availability to the patient; d) carry appropriate coverage for legal liability; e) disclose any potential conflict of interest as both a prescriber and dispenser of medication; and, f) if the pharmacist changes a physician's prescription, advise the physician of the change(s).
Drug testing in the workplace (Update 2001)
https://policybase.cma.ca/en/permalink/policy194
- Last Reviewed
- 2018-03-03
- Date
- 2001-05-28
- Topics
- Ethics and medical professionalism
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
1 document
- Policy Type
- Policy document
- Last Reviewed
- 2018-03-03
- Date
- 2001-05-28
- Replaces
- Drug testing in the workplace (1992)
Documents
Non-medicinal ingredients in drug products
https://policybase.cma.ca/en/permalink/policy802
- Last Reviewed
- 2017-03-04
- Date
- 1985-08-25
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC85-28
- The Canadian Medical Association calls on Health Canada to facilitate the dissemination of information to health professionals and consumers concerning the presence, in drug products, of non-medicinal ingredients that can cause adverse reactions.
- Policy Type
- Policy resolution
- Last Reviewed
- 2017-03-04
- Date
- 1985-08-25
- Resolution
- GC85-28
- The Canadian Medical Association calls on Health Canada to facilitate the dissemination of information to health professionals and consumers concerning the presence, in drug products, of non-medicinal ingredients that can cause adverse reactions.